KXV01 TCR Lentinvivo Injection
KXV01-R101-08
Phase 1 small_molecule active
Quick answer
KXV01 TCR Lentinvivo Injection for Advanced Solid Tumors is a Phase 1 program (small_molecule) at TScan Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TScan Therapeutics
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active